ReviewFrontiers in psychology2026
Bodily experiences in multiple sclerosis: functional neurological symptoms, body image dissatisfaction, and disordered eating behaviors. A narrative review.
Review in Frontiers in psychology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multiple sclerosis (MS) is a chronic disease of the central nervous system, associated with a range of physical, cognitive, and psychological difficulties. Beyond classical neurological symptoms, disturbances in bodily experience, including functional neurological symptoms, somatization, body-image disturbances, and disordered eating behaviors, represent an underrecognized, yet clinically relevant dimension of the disease. This narrative review synthesizes evidence from adult and pediatric populations, highlighting the frequent co-occurrence of these disturbances with MS and their associations with psychological symptoms, reduced quality of life, and functional impairment. Across studies, these manifestations appear to be shaped by a complex interplay of psychological vulnerability (e.g., depression, anxiety, perceived stigma, and low self-esteem), disease-related characteristics (such as disability level and disease course), and contextual factors including stress and treatment experiences, rather than being solely attributable to neurological pathology, such as demyelinating lesions, axonal damage, or brain atrophy. Notably, the relationship with objective disease markers is often modest or inconsistent, underscoring the importance of considering non-organic contributors to bodily experience. The limited available literature suggests that disturbances in bodily experience represent a clinically relevant yet underexplored dimension of MS, particularly in pediatric populations, warranting greater attention in both research and clinical assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.